Search Results - "Durgin, Lori M."

Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma by Chakrabarti, Sakti, Zemla, Tyler J., Ahn, Daniel H., Ou, Fang‐Shu, Fruth, Briant, Borad, Mitesh J., Hartgers, Mindy L., Wessling, Jaclynn, Walkes, Rachel L., Alberts, Steven R., McWilliams, Robert R., Liu, Minetta C., Durgin, Lori M., Bekaii‐Saab, Tanios S., Mahipal, Amit

“…Lessons Learned Trifluridine/tipiracil (FTD/TPI) shows promising antitumor activity in heavily pretreated patients with advanced biliary tract carcinoma,…”
Get full text

Phase II trial of trifluridine/tipiracil and irinotecan for the treatment of advanced refractory biliary tract cancer by Xie, Hao, Borad, Mitesh J., Ahn, Daniel H., Bekaii-Saab, Tanios S., Tran, Nguyen H., Jin, Zhaohui, Pitot, Henry C., Huebner, Lucas J., Shi, Qian, Wessling, Jaclynn, Durgin, Lori M., Liu, Minetta C., Hogenson, Tara L., Phillips, William J, Fernandez-Zapico, Martin, Alberts, Steven R, Mahipal, Amit

“…Abstract only TPS594 Background: Effective treatment options are very limited for patients with advanced refractory biliary tract cancer (BTC)…”
Get full text